- Remark Holdings is set to open moderately lower, alongside other stocks.
- A small stake in a company backed by Dr. Mehmet Oz may help the shares rise, especially if it reaches an IPO.
- Demand for coronavirus-related products could also boost NASDAQ:MARK.
NASDAQ:MARK is trading around $2.50 in pre-market trading, marginally lower. That comes after Remark Holdings Inc advanced to $2.62 on Monday, alongside the broader stock market.
It has set a higher lows but also lower highs in recent days – a narrowing range in comparison to May's rally from around $0.50 to a peak close of $3.40. Where next for the stock?
Mark stock news
The S&P 500 is set for a correction after erasing all the losses for the year. Investors are becoming more cautious ahead of Wednesday's Federal Reserve decision. The central bank may opt to take a break after stimulating the economy in response to the coronavirus crisis, and the robust rally needs occasional breathers.
Another fear is the second wave of COVID-19 cases. While Europe, most of Asia, and the original US hotspots have the disease under control, cases are rising in other American states and in Latin America.
That may be favorable for Remark Holdings, which makes thermal scanners, such as those used to detect people who have a high fever. The kit, already in use in the company's home state of Nevada, joins other AI products that are in demand, especially in China.
The Las Vegas-based company also received a "strong-buy" recommendation from Zacks, potentially sending additional investors its way.
Another reason to rise could be Remark's stake at Sharecare. The startup firm was co-founded by celebrity doctor Mehmet Oz and is also backed by Oprah Winfrey and Sony. If the company goes for an IPO, Remark's holding in the small firm could further boost its worth.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD clings to gains above 1.0750 after US data
EUR/USD manages to hold in positive territory above 1.0750 despite retreating from the fresh multi-week high it set above 1.0800 earlier in the day. The US Dollar struggles to find demand following the weaker-than-expected NFP data.
GBP/USD declines below 1.2550 following NFP-inspired upsurge
GBP/USD struggles to preserve its bullish momentum and trades below 1.2550 in the American session. Earlier in the day, the disappointing April jobs report from the US triggered a USD selloff and allowed the pair to reach multi-week highs above 1.2600.
Gold struggles to hold above $2,300 despite falling US yields
Gold stays on the back foot below $2,300 in the American session on Friday. The benchmark 10-year US Treasury bond yield stays in negative territory below 4.6% after weak US data but the improving risk mood doesn't allow XAU/USD to gain traction.
Bitcoin Weekly Forecast: Should you buy BTC here? Premium
Bitcoin (BTC) price shows signs of a potential reversal but lacks confirmation, which has divided the investor community into two – those who are buying the dips and those who are expecting a further correction.
Week ahead – BoE and RBA decisions headline a calm week
Bank of England meets on Thursday, unlikely to signal rate cuts. Reserve Bank of Australia could maintain a higher-for-longer stance. Elsewhere, Bank of Japan releases summary of opinions.